Vilaprisan, a New Selective Progesterone Receptor Modulator in Uterine Fibroid Pharmacotherapy-Will it Really be a Breakthrough?

Michał Ciebiera, Grzegorz Jakiel, Simone Ferrero et al.|Current Pharmaceutical Design|2020

Cited by 21